علاج نقص النحاس في المرضى الذين لديهم تاريخ من جراحة تحويل مسار السمنة

References

DOI: 10.1002/ncp.10328

For moderate deficiency (ie, values 8–12 μmol/L, 0.5–0.8 mg/dL), the American Society for Metabolic and Bariatric Surgery Clinical Practice (ASMBS) guidelines and the British Obesity and Metabolic Surgery Society (BOMSS) recommend the administration of 3–8 mg/d of copper sulfate or gluconate until level normalization or symptom resolution.

With proper treatment, hematologic manifestations should normalize by 12 weeks, whereas evolution of neurologic symptoms is unclear.